Subject
Developmental Biology,Reproductive Medicine,Obstetrics and Gynecology
Reference45 articles.
1. High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients;Alviggi;Eur. Rev. Med. Pharmacol. Sci.,2017
2. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization;Azim;J. Clin. Endocrinol. Metab.,2007
3. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study;Azim;J. Clin. Oncol.,2008
4. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols;Ben-Haroush;Isr. Med. Assoc. J.,2011
5. Efficacy and safety of controlled ovarian stimulation with or without letrozole co-administration for fertility preservation: a systematic review and meta-analysis;Bonardi;Front. Oncol.,2020
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献